Insight Genetics, a molecular diagnostics company focused on advancing
precision medicine in cancer care, today announced that its Quality
Management System has received ISO 9001:2008 certification. This
... read more
Insight Genetics, a molecular diagnostics company focused on advancing
precision medicine in cancer care, announced today that it will present
new data on triple-negative lung cancer at the ... read more
Insight Genetics, which has developed a diagnostic test that can more
accurately determine if certain lung cancer patients will respond to
targeted therapies, has been selected by the National Cancer Institute
... read more
NASHVILLE, TN -- (Marketwire) -- 12/14/10 -- Insight Genetics today announced that it has entered into an exclusive worldwide licensing agreement with St. Jude Children's Research Hospital that will help the company create a new diagnostic test that will assist physicians in monitoring cancer patients and make more ... read more
NASHVILLE, TN -- (Marketwire) -- 11/16/10 -- Insight Genetics today announced that it has been awarded a $244,479 grant to advance the development of novel molecular diagnostic tests for cancer. The grant was awarded by the Internal Revenue Service and the U.S. Department of Health and Human Services ... read more
NASHVILLE, TN -- (Marketwire) -- 11/09/10 -- Insight Genetics today announced that it has been awarded a $200,000 Phase I Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI) to develop a new test for lung cancer patients. The contract was awarded as part of ... read more